期刊文献+

胆囊神经内分泌癌10例单中心临床分析 被引量:13

Neuroendocrine carcinoma of the gallbladder: ten cases in a single institution
原文传递
导出
摘要 目的 总结分析胆囊神经内分泌癌(GB-NEC)的临床特征及诊治经验.方法 回顾性分析10例GB-NEC患者资料,并与同期377例胆囊腺癌比较.结果 GB-NEC患者占同期胆囊癌患者总数的2.2% (10/464).患者平均年龄(59.0±10.0)岁,男女之比1∶4.10例患者均为低分化小细胞GB-NEC,4例合并腺癌.免疫组化CgA、NSE、Syn、EMA阳性率分别为100% (10/10)、100%(10/10)、88.9% (8/9)、87.5% (7/8).TNM分期Ⅱ期1例,ⅣA期2例,ⅣB期7例,N2淋巴结转移达70.0% (7/10),明显高于同期胆囊腺癌的34.0%(128/377,P<0.05).2例行根治性切除手术,8例行姑息性手术.10例GB-NEC患者1年、2年、3年生存率分别为20.0% (2/10)、10.0% (1/10)、0,中位生存时间为92 d.同期胆囊腺癌患者1年、3年、5年生存率分别为32.7%、21.3%、11.7%,中位生存时间为180 d.结论 GB-NEC多发于老年女性,临床表现无特异性,确诊依赖于免疫组化检查.该类肿瘤恶性程度高,早期即可发生局部浸润和淋巴转移,其预后较胆囊腺癌更差.手术治疗为其首选、主要的治疗手段,联合放化疗及TACE等多种治疗手段有助于延长患者生存时间. Objective To summarize and analyse the clinical characteristics,diagnosis and treatment options of neuroendocrine carcinoma of gallbladder (GB-NEC).Methods The data of 10 patients with GB-NEC treated in our hospital between December 2007 and December 2012 were retrospectively analyzed and compared with the data of 377 patients with gallbladder adenocarcinoma.Results The 10 patients with GB-NEC accounted for 2.2% (10/464) of all gallbladder cancers that were treated during the study period.The mean age was 59.0 ± 10.0 years,the ratio of male to female was 1 ∶ 4.All the 10 patients had low-differentiated small cell NEC,four patients were accompanied with an adenocarcinoma.Immunohistochemical examinations showed that the positive rates of CgA,NSE,Syn,EMA were 100% (10/10),100% (10/10),88.9% (8/9) and 87.5% (7/8),respectively.One,two and seven patients had a TNM grade Ⅱ,ⅣA,and ⅣB,respectively.Seven patients (70.0%) had N2 lymphatic metastases,which was significantly higher than the percentage in patients with gallbladder adenocarcinoma (128/377,34.0% ; P 〈 0.05).Two patients were treated with radical resection,while the other 8 patients were treated with palliative surgery.The 1-,2-,and 3-year survival rates of the patients with GB-NEC were 20.0%,10.0%,and 0,respectively.The median survival time was 92 days.In contrast,the 1-,2-,3-,and 5-year survival rates of the 377 patients with gallbladder adenocarcinoma were 32.7%,25.4%,21.3%,and 11.7% respectively,and the median survival time was 180 days.Condusions GB-NEC was found mainly in aged females.The clinical presentations were mainly non-specific,and immunohistochemical examinations were needed for a definite diagnosis.GB-NEC is highly malignant,and local invasion and lymphatic metastasis could occur early.The short-term recurrence rate was very high.The prognosis of GB-NEC was poorer than gallbladder adenocarcinoma,while surgical resection combined with radiotherapy,chemotherapy and TACE increased the survival of these patients.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第3期177-180,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 胆囊肿瘤 神经内分泌肿瘤 外科治疗 预后 Gallbladder tumor Neuroendocrine tumor Surgical treatment Prognosis
  • 相关文献

参考文献18

  • 1Rothenstein J, Cleary SP, Pond GR, et al. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital [J]. Am J Clin Oncol, 2(108,31(1):64-70.
  • 2Oberg K. Diagnostic work-up of gastroenteropancreatic neuroendo- crine tumors [J]. Clinics ( San Paulo), 2012,67 ( Suppl 1 ) : 109-112.
  • 3Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 car- cinoid tumors [ J]. Cancer, 2003,97 (4) :934-959.
  • 4Modlin IM, Shapiro MD, Kidd M. An analysis of rare careinoid tumors: clarifying these clinical conundrums [J]. World J Surg, 2005,29( 1 ) :92-101.
  • 5Yao JC, Hassan M, Phan A, et al. One hundred years after "car- cinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States [ J]. J Clin Oncol, 2008,26 ( 18 ) : 3063-3072.
  • 6Bosman FT. World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system [M] .4th ed. Lyon: IARC Press, 2010:417.
  • 7Kim J, Lee WJ, Lee SH, et al. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours [ J ]. Dig Liver Dis, 2011,43 ( 12 ) :965-970.
  • 8Lee JM, Hwang S, Lee SG, et al. Neuroendocrine tumors of the gallbladder: twelve cases in a single institution [ J ]. Hepatogastroenterology, 2010,57 ( 102-103 ) : 1064-1068.
  • 9黄明德,祁付珍.胆囊神经内分泌癌并发胆囊结石一例[J].中华普通外科杂志,2013,28(3):243-243. 被引量:4
  • 10Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC) : 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC) [ J]. J Surg Oneol, 2008,98 (7) :485-489.

二级参考文献25

  • 1Eltawil KM, Gustafsson, Kidd M, Modlin IM,et al. Neuroeodocrine Tumors of the Gallbladder: An Evaluation and Reassessment of Management Strategy. J Clin Gastroenterol,2010 ,44 :687-695.
  • 2lype S, Mirza TA, Propper DJ, et al. Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J, 2009,85:213-218.
  • 3Yang XW, Yang J, Li L, et al. Analysis of the relationships be- tween clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent [ J ]. Plos One, 2012,7(12) :e51513.
  • 4Yuan Y, Yang ZL, Zou Q, et al. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 ex- pression in benign and malignant lesions of the gallbladder [J].Polish J Pathology,2013,64( 1 ) :44-51.
  • 5Boutros C, Gary M, Baldwin K, et al. Gallbladder cancer: past, present and an uncertain future [J].Surg Onct)log ( Oxford), 2012,21 (4) :e183-191.
  • 6D'handt M, Lapointe R, Benamira Z, et al. Carcinoma of the gall- bladder: Patterns of presentation, prognostic factors and survival rate: an ll-year single centre experience [ J ]. Ejso, 2013,39 (6) :548-553,.
  • 7Meng H, Wang X, Fong Y, et at. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases [ J ]. Jap J Clin Oneol,2011,41 (8) :992-998.
  • 8Sakamoto Y, Nara S, Kishi Y, et al. ls extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? [ J ]. Surgery, 2013,153 (6) : 794 -800.
  • 9Horignchi A, Miyakawa S, Ishihara S,et al. Gallbladder bed resec- tion or hepatectomy of segments 4a and 5 for pT2 gallbladder car- cinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pan- creatic Surgery [ J]. J Hepato Biliary Pancreatic Sci,2013,20 (5) :518-524.
  • 10Hueman MT,Vollmer CM,Pawlik TM.Evolving treatment strategies for gallbladder cancer[J].Ann Surg Oncol,2009,16(8):2010-2115.

共引文献46

同被引文献63

  • 1张小弟,霍永江,张天政,魏志力,张毅.胆管神经内分泌癌的诊断和治疗[J].医学信息(西安上半月),2006,19(12):2174-2176. 被引量:5
  • 2蒋建霞,施瑞华,林琳.消化系神经内分泌癌及文献分析209例[J].世界华人消化杂志,2007,15(4):421-426. 被引量:34
  • 3World Health Organization. World Health Organization classification of tumours of the digestive system[ J ]. 2010. DOI: 10. 1016/ j. annpat. 2011.01. 001.
  • 4Kopelman D, Schein M, Kerner H, et al. Carcinoid tumor of the common bile duct [ J]. HPB Surgery, 1996,10 ( 1 ) :41. DOI : 10. 1155/1996/51493.
  • 5Valle J, Wasan H, Palmer D H, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[ J]. New Engl J Med, 2010,362(14) :1273-1281. DOI:10. 1056/NEJMoa0908721.
  • 6Modlin IM,Lye KD,Kidd M. A 5-decade analysis of 13,715 car- cinoid tumors[J]. Cancer, 200a, 97 (4) : 934-959.
  • 7Luttges J. What's new? The 2010 WHO classification for tumours of the pancreas[J]. Pathologe,2011,32 (Suppl 2):332-336.
  • 8Monier A, Saloum N, Szmigielski W, et al. Neuroendocrine tumor of the gallbladder[J]. Pol J Radiol,2015,80:228-231.
  • 9Yao JC,Hassan M,Phan A,et al. One hundred years after "car- cinoid": epidemiology of and prognostic factors for neuroendo- crine tumors in 35,825 cases in the United States[J].J Clin On-col,2008,26(18):3063-3072.
  • 10Meoni G, Antonuzzo L, Messerini L, et al. Gallbladder neuroen- docrine neoplasm: a case report and critical evaluation of WHO classification[J]. Endocr J, 2014,61(10) : 989-994.

引证文献13

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部